Teva Fined Half A Billion Dollars Over European Copaxone Antitrust Breach

Firm Says Decision Is ‘Not Supported By Facts’ And Vows Appeal

 
• By Dave Wallace
  
The European Commission provided an explanatory infographic (European Commission)

More from Biosimilars & Generics

More from Italy